EMA
- Application: EMEA/H/C/005682
- Marketing authorisation holder: Gedeon Richter Plc.
- Local brand name: Vivjoa
- Status: withdrawn
Vivjoa (OTESECONAZOLE) regulatory status in European Union.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA has authorised it.
Gedeon Richter Plc. holds the EU marketing authorisation.